PULSE BIOSCIENCES, INC. — Director's Dealing 2020

Jun 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2020-06-15

Reporting Person: Levinson Mitchell E. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-15	Common Stock	X	5713	$7.01	Acquired	25713	Direct
2020-06-15	Common Stock	X	714	$7.01	Acquired	3214	Indirect
2020-06-15	Common Stock	X	127	$7.01	Acquired	572	Indirect
2020-06-15	Common Stock	X	127	$7.01	Acquired	572	Indirect
2020-06-15	Common Stock	X	127	$7.01	Acquired	572	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-15	Warrant (right to buy)	$7.01	P	856	Acquired	2025-06-15	Common Stock (856)	Direct
2020-06-15	Warrant (right to buy)	$7.01	P	107	Acquired	2025-06-15	Common Stock (107)	Indirect
2020-06-15	Warrant (right to buy)	$7.01	P	19	Acquired	2025-06-15	Common Stock (19)	Indirect
2020-06-15	Warrant (right to buy)	$7.01	P	19	Acquired	2025-06-15	Common Stock (19)	Indirect
2020-06-15	Warrant (right to buy)	$7.01	P	19	Acquired	2025-06-15	Common Stock (19)	Indirect

Footnotes

F1: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC.